Hidradenitis Suppurativa: When Reality Outpaces Discovery

Hidradenitis Suppurativa: When Reality Outpaces Discovery

Hidradenitis suppurativa is a common disease, but the evidence defining it has failed to keep pace with its clinical burden. Although it is a chronic inflammatory skin condition, it remains widely misunderstood and underdiagnosed. For many patients, its impact extends...
December Focus: Staying Effective in a High-Demand Access Season

December Focus: Staying Effective in a High-Demand Access Season

December stands as one of the highest-pressure operational cycles for dermatology access teams. PAP renewals, insurance transitions, Medicare changes, and January preparations often hit simultaneously, creating a fast-paced landscape where disciplined time management...
When Copay Cards Max Out: End-of-Year Tips for Biologic Patients

When Copay Cards Max Out: End-of-Year Tips for Biologic Patients

As we approach the end of the year, many patients on biologic therapies start noticing something unexpected — their copay cards have reached their annual maximum. For patients relying on these high-cost specialty medications, this can be stressful and confusing. But...